Endologix (ELGX) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
General and administrative: 9.71M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
General and administrative: 9.71M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Endologix (NASDAQ: ELGX) reported Q1 EPS of ($0.24), $0.07 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $42.3 million versus the consensus estimate of $41.27 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- McDonald's posts better-than-expected third-quarter comparable sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
